PATENT CLAIM ANALYSIS

Application Number: 16283926
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-10
Patent Classification: ["514", "221000"]

Abstract:
Described herein are α3 or α2 or α2/α3 GABAergic receptor subtype selective ligands, pharmaceutical compositions, and methods of use of such ligands and compositions in treatment of anxiety disorders, epilepsy and schizophrenia with reduced sedative and ataxic side effects. In embodiments, such as α3 or α2 or α2/α3 GABAergic receptor subtype selective ligands lack ester linkages and may be thus relatively insensitive to hydrolysis by esterases.

Claim (Index 34):
The pharmaceutical composition of  claim 33 , wherein said surfactant is Tween 80.

Metadata:
- Claim Count in Document: 56.0
- Percentile: 99.0
- Lexical Diversity: 1.5
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15560002', '13458168', '14637334', '11383624', '10333151']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7754155918119846
- 35 USC 102 Novelty (BERT): 0.5984015276199797
- Combined Prediction Score: 0.7577141853927841
- Mean Citation Score: 382.309016
- Max Citation Score: 619.8617
- Similarity Product: 399.3217589971781

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test